SynBiotic SE
Research SynBiotic SE (SBX) on Bullrun: market cap EUR 7.69M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSBX
- ExchangeXETRA
- CountryGermany
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 7.69M
- Financial periodFY2024
- RevenueEUR 14.31M
- Revenue growth270.5%
- Net income-EUR 9.72M
- Free cash flow-EUR 726.07K
- Gross margin34.0%
Valuation Snapshot
latest market cap is EUR 7.69M.
About SynBiotic SE
SynBiotic SE engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety. It also offers hemp, cannabinoids, dietary supplements, and cosmetic products; medical cannabis products; and cannabis products for recreational use under the Hempamed, Princess Stardust, The Hempany, and Hempamed Rx brand names. The company was formerly known as Ledgertech SE and changed its name to SynBiotic SE.
Frequently asked questions
What is SynBiotic SE's market cap?
SynBiotic SE's market capitalization is EUR 7.69M.
What does SynBiotic SE do?
SynBiotic SE engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety. It also offers hemp, cannabinoids, dietary supplements, and cosmetic products; medical cannabis products;